Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.889,70
0,16%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Edwards Lifesciences Corp (EW) Edwards Lifesciences Corp (EW) Notizie

EW

Edwards Lifesciences (EW)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:EW
DataOraFonteTitoloSimboloCompagnia
10/05/202422:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
09/05/202411:13Business WireEdwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vorNYSE:EWEdwards Lifesciences Corp
09/05/202411:13Business WireEdwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilitéNYSE:EWEdwards Lifesciences Corp
09/05/202401:21Business WireEdwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance DurabilityNYSE:EWEdwards Lifesciences Corp
08/05/202422:52Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
07/05/202423:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
25/04/202422:15Business WireEdwards Lifesciences Reports First Quarter ResultsNYSE:EWEdwards Lifesciences Corp
18/04/202413:10Business WireEdwards Lifesciences to Host Earnings Conference Call on April 25, 2024NYSE:EWEdwards Lifesciences Corp
07/04/202422:30Business WireStudy of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing ItNYSE:EWEdwards Lifesciences Corp
11/03/202419:00Business WireLarge, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVRNYSE:EWEdwards Lifesciences Corp
23/02/202413:05Business WireEdwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare ConferenceNYSE:EWEdwards Lifesciences Corp
12/02/202422:47Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EWEdwards Lifesciences Corp
06/02/202422:15Business WireEdwards Lifesciences Reports Fourth Quarter ResultsNYSE:EWEdwards Lifesciences Corp
02/02/202413:00Business WireEdwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid ValveNYSE:EWEdwards Lifesciences Corp
30/01/202413:05Business WireEdwards Lifesciences to Host Earnings Conference Call on February 6, 2024NYSE:EWEdwards Lifesciences Corp
25/01/202419:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:EWEdwards Lifesciences Corp
02/01/202415:00Business WireEdwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:EWEdwards Lifesciences Corp
07/12/202314:30Business WireEdwards Lifesciences Outlines Growth Strategy at Annual Investor ConferenceNYSE:EWEdwards Lifesciences Corp
28/11/202313:06IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNYSE:EWEdwards Lifesciences Corp
27/10/202322:49Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EWEdwards Lifesciences Corp
26/10/202321:06PR Newswire (US)CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATIONNYSE:EWEdwards Lifesciences Corp
26/10/202320:00PR Newswire (US)TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATIONNYSE:EWEdwards Lifesciences Corp
25/10/202322:15PR Newswire (US)EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTSNYSE:EWEdwards Lifesciences Corp
24/10/202320:00PR Newswire (US)FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVENYSE:EWEdwards Lifesciences Corp
19/10/202314:30PR Newswire (US)EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARKNYSE:EWEdwards Lifesciences Corp
18/10/202313:05PR Newswire (US)EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023NYSE:EWEdwards Lifesciences Corp
08/09/202316:08IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNYSE:EWEdwards Lifesciences Corp
28/08/202314:10PR Newswire (US)EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCENYSE:EWEdwards Lifesciences Corp
02/08/202317:58Dow Jones NewsCorrection to Edwards Lifesciences 2Q Net Headline on July 26NYSE:EWEdwards Lifesciences Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:EW

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network